Chelsea Therapeutics.

PositionCHARLOTTE - Pharmaceutical industry - Brief Article

CHARLOTTE -- Chelsea Therapeutics raised $14.5 million to help finance tests of a compound aimed at treating rheumatoid arthritis, psoriasis and some cancers. The company hopes to start selling the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT